Showing posts with the label 2024Show all
In-silico drug design of some bioactive compounds against BRCA1 for treatment of cancer
Corresponding Author: Md. Abdul Kader Shakil Email: shakil@bsmrstu.edu.bd Abul Bashar Ripon Khalipha Email: khalipha1982@gmail.com Md. Abdul Kader Shakil b *, …
Read Full Article
PHYTOCHEMICAL SCREENING, CYTOTOXICITY TEST AND DETERMINATION OF ANTIOXIDANT ACTIVITY OF METHANOLIC EXTRACT OF LITSEA SERBIFERA LEAVES; IN-VITRO and IN-SILICO STUDY
Abul Bashar Ripon Khalipha1 *, Sukalyan Kumar Kundu, PhD 2, Dr. Md. Nur Alam 2 , Md. Emdad Hossain, PhD 3 1 Department of Pharmacy, Life Science Faculty, B…
Read Full Article
IN SILICO APPROACHES OF (E)-PHYTOL TO INHIBIT THE ACTIVITY OF PREVENTING SARS-COV-2 AND COLORECTAL CANCER
IN SILICO APPROACHES OF (E)-PHYTOL TO INHIBIT THE ACTIVITY OF PREVENTING SARS-COV-2 AND COLORECTAL CANCER Abul Bashar Ripon Khalipha 1.2 *, Khadiza Akter 1…
Read Full Article
Computer-Aided Drug Design of Limonene for Cancer Therapy
Computer-Aided Drug Design of Limonene for Cancer Therapy Abul Bashar Ripon Khalipha 1, 3 *, Sukalyan Kumar Kundu, PhD 2 , Dr. Md. Nur Alam 2 Khadiz…
Read Full Article
OnnoRokom Group is a dynamic organization that actively supports innovative initiatives, including "International Journal of In-Silico Drug Design (IJISDD)". Their dedication to fostering technological and educational advancements has made them a prominent sponsor in the industry.
Learn more about them at OnnoRokom Group.
International Journal of In-Silico Drug Design (IJISDD) is a multidisciplinary platform at the intersection of computing, pharmacology, toxicology, and pharmaceutics. Focused on neuroscience, drug discovery, and multiscale modeling, it encourages deterministic and stochastic modeling of biological processes. Learn More...
Connect US